Excel Industries Ltd
Excel Industries Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #60 of 71 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
What the Q4 FY26 call signalled
1 of 3 strong
The short version
Excel Industries aims for growth by focusing on Performance Solutions, contract manufacturing, and YP derivatives as key growth drivers. Excel Industries aims for growth through capex deployment in key areas: Performance Solutions, contract manufacturing, and YP derivatives.
From Excel Industries Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Excel Industries aims for growth by focusing on Performance Solutions, contract manufacturing, and YP derivatives as key growth drivers.
- Export share is expected to increase, especially by expanding presence in the EU and potentially the US markets.
- Contract manufacturing is seen as a growing segment, with more international multinational customer deals expected.
- The company plans to launch new products, particularly in the biocides segment, to drive revenue.
- Capacity utilization currently ranges from 65% to 85%, with planned capacity additions targeting focus areas.
2 more points from Excel Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Excel Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Excel Industries plans capex of around INR 200-300 crores over the next 2-3 years, targeting key growth areas.
- Focus areas for capex include Performance Solutions, contract manufacturing, and YP derivatives.
- Fixed asset turnover expected to be 1 to 1.5 times, with an expected ROI of 15%-20%.
- Capex deployment details will be disclosed as and when significant investments occur.
- Company remains open to inorganic capex where strategic opportunities provide technology or market access.
- Additional capacity is maintained to manage cyclicity and supply chain disruptions, ensuring customer servicing and opportunity capture.
2 more points from Excel Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Excel Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Ravi Shroff mentioned ongoing contract manufacturing agreements progressing well, with validation batches dispatched and capacity expected to come on stream by July 2026.
- New product launches (e.g., biocides) in Performance Solutions segment are planned, indicating a pipeline of growth opportunities.
- The company is actively pursuing growth through exports, contract manufacturing, and Performance Solutions, suggesting a positive outlook on order inflow.
- Exact order book size or pending orders data were not shared due to commercial confidentiality and the early stage of some projects.
Excel Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹281 Cr, net profit ₹12 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Excel Industries Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Indian Phosphate Ltd (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- Paragon Fine (Q4 FY26)
Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p
- IVP Ltd (Q4 FY26)
Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector
- Vishnu Chemicals Ltd (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Excel Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Excel Industries Ltd Q4 FY26 results?
Excel Industries aims for growth by focusing on Performance Solutions, contract manufacturing, and YP derivatives as key growth drivers. Excel Industries aims for growth through capex deployment in key areas: Performance Solutions, contract manufacturing, and YP derivatives.
What is Excel Industries Ltd share price analysis?
Excel Industries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 17.9 with a market cap of ₹1,274 Cr. Investors should review the full earnings analysis for detailed insights.
Is Excel Industries Ltd planning capital expenditure?
Excel Industries plans capex of around INR 200-300 crores over the next 2-3 years, targeting key growth areas.
Keep Excel Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.